---
category: news
title: "iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval"
abstract: "artificial intelligence technology assists radiologists in detecting breast cancer NASHUA, N.H., July 11, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions ..."
publishedDateTime: 2019-07-11T13:00:00Z
sourceUrl: https://www.nasdaq.com/press-release/icads-profound-ai-for-2d-mammography-receives-ce-mark-approval-20190711-00316
type: article
score: 23
published: false

provider:
  name: Nasdaq
  id: nasdaq.com

topics:
  - AI
  - AI in Healthcare
---
